Sunday, September 04, 2022 10:06:34 PM
Recap:
The uplist is the major catalyst. It will be an IPO like event that will create significant upside based on recent fundamentals and year over year growth. Institutions will lock up shares and create price stability at a much higher level revealing a proper valuation. My educated guess would be 5/6X current revs. You can do the math.
Wild cards…
China/SEC auditing FUD
Centurium’s hold on majority shares create some concerns given their leverage.
Recent LKNCY News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 11:24:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:34:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 12:00:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 04:40:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/16/2023 11:30:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 11:35:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/10/2023 02:28:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/03/2023 09:09:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 11:00:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/07/2023 02:31:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2023 11:35:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:09:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:03:46 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 11:00:26 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM